Dasatinib may override F317L BCR-ABL kinase domain mutation in patients with chronic myeloid leukemia

Ahmet Emre EŞKAZAN,Teoman SOYSAL

Dergi

Turkish Journal of Hematology

Sayı

2013 · Cilt: 30 - Sayı: 2

Sayfa

211–213

DOI

—